Results 151 to 160 of about 12,698 (210)
Solid Lipid Nanoparticles as Delivery Systems for Bromocriptine
Pharmaceutical Research, 2008 Purpose. The present investigation describes a formulative study for the development of innovative drug delivery systems for bromocriptine. Methods.
Markus Drechsler +2 more
exaly +2 more sources
Postpartum Cerebral Angiopathy Possibly Due to Bromocriptine Therapy
Stroke, 1995 Background Eight cases of benign angiopathy of the postpartum period have been reported previously, none of which involved the administration of bromocriptine.
Didier Leys, F Mounier-Vehier, M Hommel
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Headache: The Journal of Head and Face Pain, 1976
SYNOPSIS Seven women with early menstrual or premenstrual migraine were given CB154 (Bromocriptine) over 15 menstrual cycles. In 12 menstrual cycles only one migraine attack occurred. Bromocriptine in a dose of 1 mg tid. at 4 day intervals was effective in relieving menstrual migraine and major symptoms of the premenstrual syndrome in
J M, Hockaday, K M, Peet, T D, Hockaday
openaire +2 more sources
SYNOPSIS Seven women with early menstrual or premenstrual migraine were given CB154 (Bromocriptine) over 15 menstrual cycles. In 12 menstrual cycles only one migraine attack occurred. Bromocriptine in a dose of 1 mg tid. at 4 day intervals was effective in relieving menstrual migraine and major symptoms of the premenstrual syndrome in
J M, Hockaday, K M, Peet, T D, Hockaday
openaire +2 more sources
Immunomodulation by bromocriptine
Immunopharmacology, 1983Treatment of rats with the dopaminergic ergot alkaloid bromocriptine (BRC) inhibited the following immune reactions: contact sensitivity skin reaction to dinitrochlorobenzene (DNCB); antibody formation to sheep red blood cells and to bacterial lipopolysaccharide; adjuvant arthritis; and experimental allergic encephalitis. Immunosuppressive doses of BRC
E, Nagy +4 more
openaire +2 more sources
Annals of Internal Medicine, 1979
Excerpt To the editor: The excellent and valuable review in the June issue by Drs. Spark and Dickstein, "Bromocriptine and Endocrine Disorders" (1), referred to the potential teratogenicity of this...
R L, Elton, H M, Langrall
openaire +2 more sources
Excerpt To the editor: The excellent and valuable review in the June issue by Drs. Spark and Dickstein, "Bromocriptine and Endocrine Disorders" (1), referred to the potential teratogenicity of this...
R L, Elton, H M, Langrall
openaire +2 more sources
Current Medical Research and Opinion, 1982
A double-blind trial was carried out in 9 patients with endogenous depression to compare the effectiveness of bromocriptine (15 mg per day, 4 patients) with that of imipramine (75 mg per day, 5 patients) over a period of 10 weeks. The results of assessments using the Hamilton Rating Scale for Depression showed that both drugs produced comparable ...
N, Bouras, P K, Bridges
openaire +2 more sources
A double-blind trial was carried out in 9 patients with endogenous depression to compare the effectiveness of bromocriptine (15 mg per day, 4 patients) with that of imipramine (75 mg per day, 5 patients) over a period of 10 weeks. The results of assessments using the Hamilton Rating Scale for Depression showed that both drugs produced comparable ...
N, Bouras, P K, Bridges
openaire +2 more sources
Bromocriptine and Hallucinations
Annals of Internal Medicine, 1984Excerpt To the editor: Vance and associates (1) state in their review on bromocriptine, "Hallucinations have been associated with bromocriptine treatment in patients with Parkinson's disease but ar...
openaire +2 more sources